Valuation: DexCom, Inc.

Market Cap 3.25TCr 16TCr 2.89TCr 2.68TCr 2.44TCr 4.57TCr 3,07800Cr 4.65TCr 32TCr 13TCr 1,60900Cr 12TCr 12TCr 5,14300Cr P/E 2026 *
34.6x
P/E 2027 * 29.1x
Enterprise Value 3.17TCr 16TCr 2.83TCr 2.62TCr 2.38TCr 4.47TCr 3,00600Cr 4.54TCr 31TCr 12TCr 1,57100Cr 12TCr 12TCr 5,02300Cr EV / Sales 2026 *
6.06x
EV / Sales 2027 * 5.42x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-7.95%
1 week-2.06%
Current month-3.92%
1 month-5.82%
3 months+17.88%
6 months+33.28%
Current year+14.42%
1 week 8.57
Extreme 8.57
8.75
1 month 8.16
Extreme 8.16
9.22
Current year 5.75
Extreme 5.75
9.57
1 year 5.75
Extreme 5.75
9.57
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-7.95%-2.06% - - 3.25TCr
-0.86%+2.11%-19.72%+8.94% 18TCr
-2.02%+0.89%-3.31%+28.19% 12TCr
+1.33%+5.66%-21.68%+11.24% 11TCr
-1.52%+3.61%-51.56%-6.22% 7.98TCr
-0.10%+4.60%+3.85%+79.05% 6.51TCr
-0.27%+2.10%+15.54%+66.81% 5.43TCr
-0.43%+1.18%+0.06%-25.78% 5.22TCr
-0.54%+6.35%-13.40%+30.90% 4.41TCr
-0.06%-0.03%+25.52%-0.17% 3.25TCr
Average -1.24%+5.18%-7.19%+21.44% 8.21TCr
Weighted average by Cap. -0.89%+5.50%-12.45%+19.57%

Financials

2026 *2027 *
Net sales 522.93Cr 2.64TCr 466.14Cr 431.8Cr 392.61Cr 736.72Cr 50TCr 748.83Cr 5.18TCr 2.04TCr 26TCr 1.96TCr 1.92TCr 83TCr 579.3Cr 2.93TCr 516.39Cr 478.35Cr 434.94Cr 816.15Cr 55TCr 829.56Cr 5.74TCr 2.26TCr 29TCr 2.17TCr 2.13TCr 92TCr
Net income 97Cr 491.95Cr 87Cr 80Cr 73Cr 137.09Cr 9.23TCr 139.34Cr 963.73Cr 378.96Cr 4.82TCr 365.08Cr 357.44Cr 15TCr 114.57Cr 579.26Cr 102.13Cr 95Cr 86Cr 161.42Cr 11TCr 164.07Cr 1.13TCr 446.22Cr 5.68TCr 429.87Cr 420.88Cr 18TCr
Net Debt -76Cr -384.81Cr -68Cr -63Cr -57Cr -107.23Cr -7.22TCr -109Cr -753.85Cr -296.43Cr -3.77TCr -285.57Cr -279.6Cr -12TCr -106.15Cr -536.65Cr -95Cr -88Cr -80Cr -149.54Cr -10TCr -152Cr -1.05TCr -413.4Cr -5.26TCr -398.25Cr -389.92Cr -17TCr
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
19/26/19 R$8.570 -7.95% 5
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
86.04USD
Average target price
96.46USD
Spread / Average Target
+12.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DexCom, Inc.